Bankwell (BWFG) Form 4: Multiple Purchases and Restricted Stock Distributions Reported
Rhea-AI Filing Summary
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple transactions on 09/10/2025. He purchased blocks of common stock through several affiliated entities: 4,602 shares at $44.53, 1,502 shares at $44.54, 913 shares at $44.55, 2,700 shares at $44.54, 753 shares at $44.55 and 530 shares at $44.57; the Form shows the resulting beneficial ownership counts for each entity after those purchases. The filing also reports disposals tied to restricted stock vesting and a deferred compensation plan: 1,800 shares (granted 02/07/2025) with staged vesting through 2028, 1,067 shares (granted 12/29/2023) with 533 already vested, 800 shares (granted 12/30/2022) with 800 vested, 400 shares (granted 12/31/2021) with 1,200 vested to date, and a separate 15,338-share disposition related to a Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.
Positive
- Director purchases disclosed: Multiple purchases on 09/10/2025 across affiliated entities at prices $44.53–$44.57 indicate additional insider accumulation.
- Clear vesting disclosure: Footnotes specify grant dates and vesting schedules for restricted shares, improving transparency.
- Filing compliance: Form 4 executed and signed by an attorney-in-fact on 09/11/2025, showing timely disclosure.
Negative
- Dispositions reported: Multiple restricted-share dispositions and a 15,338-share Deferred Compensation Plan distribution appear in the filing.
- Fragmented beneficial ownership: Purchases are recorded across several affiliated entities, which can make aggregate insider position less immediately clear from the Form.
Insights
TL;DR: Director executed multiple small purchases across affiliated vehicles and reported scheduled vesting-related dispositions; impact appears routine.
The transactions are a mix of open-market purchases (codes "P") executed on 09/10/2025 at prices between $44.53 and $44.57 across several Seidman-controlled entities, increasing reported beneficial holdings at the entity level. Disposals reflect vesting and distribution of previously granted restricted stock and a Deferred Compensation Plan distribution; explanatory footnotes specify vesting schedules and amounts vested as of the filing date. From a market-significance perspective, these are director-level reallocations and scheduled vesting events rather than a single, large market-moving event.
TL;DR: Reporting follows Section 16 patterns: purchases by controlled entities and dispositions from planned vesting; disclosures are detailed and compliant.
The Form 4 identifies the reporting person as a director and shows individual filings by one reporting person with transactions by affiliated entities and the Deferred Compensation Plan. Explanations clearly tie disposals to specific restricted stock grants with vesting schedules and note amounts already vested. The filing was signed by an attorney-in-fact, consistent with delegated reporting practices. No omissions of grant dates or vesting terms are apparent in the provided explanations.